To investigate human natural killer (NK)-cell reactivity in vivo we have reconstituted human immune system components by transplantation of human hematopoietic progenitor cells into NOD-scid IL2R(null) mice. We demonstrate here that this model allows the development of all NK-cell subsets that are also found in human adult peripheral and cord blood, including NKp46(+)CD56(-) NK cells. Similar to human cord blood, NK cells from these reconstituted mice require preactivation by interleukin-15 to reach the functional competence of human adult NK cells. Mainly the terminally differentiated CD16(+) NK cells demonstrate lower reactivity without this stimulation. After preactivation, both CD16(+) and CD16(-) NK cells efficiently produce interferon-and degranulate in response to stimulation with NK cellsusceptible targets, including K562 erythroleukemia cells. NK-cell lines, established from reconstituted mice, demonstrate cytotoxicity against this tumor cell line. Importantly, preactivation can as well be achieved by bystander cell maturation via poly I:C stimulation in vitro and injection of this maturation stimulus in vivo. Preactivation in vivo enhances killing of human leukocyte antigen class I negative tumor cells after their adoptive transfer. These data suggest that a functional, but resting, NK-cell compartment can be established in immune-compromised mice after human hematopoietic progenitor cell transfer.
Introduction
NK cells are innate lymphocytes that are primarily thought to curb viral infections and tumor cell expansion until antigen-specific adaptive immune responses can be primed to eradicate these threats to human health (1) . In contrast to adaptive lymphocytes like T and B cells, NK cells recognize their targets through germ line encoded receptors. These receptors transmit either activating or inhibitory signals (2) (3) . The activating receptors recognize primarily stress induced molecules on infected and transformed cells, including MHC class I like molecules that serve as ligands for the activating NK cell receptor NKG2D, PVR and Nectin-2 as ligands for the activating NK cell receptor DNAM-1, and B7-H6 as well as ligands of still poorly defined identity for the natural cytotoxicity receptors (NCRs) NKp30, NKp46 and NKp44 (4) (5) . Ligands for these activating receptors are up-regulated upon for example DNA damage or heat shock (6) (7) , but are also constitutively present on some hematopoietic cells, including myeloid dendritic cells (8) , microglia (9) and activated macrophages (10) . These activating signals are balanced by inhibitory receptor engagement, recognizing classical and nonclassical MHC class I molecules. In humans, killer immunoglobulin-like receptors (KIRs) recognize polymorphic determinants of classical MHC class I molecules, and C-type lectin receptors like the CD94/NKG2 heterodimer engage the non-classical MHC class I molecule HLA-E (11) . The balance of transmitted activating and inhibitory signals decides if NK cells will mount effector functions against conjugated target cells.
The main effector characteristics of NK cells are cytokine secretion and cytotoxicity (12) , and humans carry NK cell subsets that preferentially mediate one or the other of these functions. CD56 bright CD16 -KIR -NK cells respond primarily with production of IFN-, TNF and GM-CSF to activation, and only exert cytotoxicity after prolonged activation (13) . In contrast, CD56 dim CD16 + KIR + NK cells are constitutively loaded with perforin and granzymes and are the primary human cytotoxic NK cell subset (14) . While the latter population constitutes the majority of peripheral blood NK cells, CD56 bright CD16 -KIR -NK cells are enriched in human secondary lymphoid organs (15) (16) . They have been proposed to limit pathogen invasion and polarize adaptive immune responses at these sites (12, 17) . Thus cytotoxic NK cells patrol primarily the periphery, while immunoregulatory NK cells support Th1 polarization in secondary lymphoid organs.
The developmental pathways leading to the functionally distinct human NK cell subsets are still being defined (18) . So far three alternative pathways have been proposed. Originally, it was proposed that NK cells develop exclusively in the bone marrow from which they populate the periphery as constitutively reactive innate lymphocytes (1) . After the discovery that the immunoregulatory human NK cells could acquire phenotypic and functional characteristics of cytotoxic NK cells (19) (20) (21) (22) , it was proposed that CD56 bright CD16 -KIR -NK cells could home to secondary lymphoid tissues by virtue of their CD62L and CCR7 expression and mature to CD56 bright CD16 + KIR + NK cells at these sites (23) . Alternatively, CD56 bright CD16 -KIR -NK cells might also develop directly from CD34 + precursors in secondary (24) or primary lymphoid organs (25) . In order to shed some more light on the requirements for the development of the human NK cell subsets and their functional competence, we investigated human NK cell compartments reconstituted from CD34 + hematopoietic stem and progenitor cells in NOD-scid IL2R null (hu-NSG) mice in comparison to human cord blood and adult blood NK cells. We describe here that both hu-NSG and cord blood NK cells require preactivation by monokines to reach functional competence as found in adult peripheral blood, and part of this recruitable activity lies dormant in terminally differentiated CD16 + NK cells.
Material and Methods:
Preparation of humanized mice NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ (NSG) mice were obtained from the Jackson Laboratory (Bar Harbor, ME) and raised under specific pathogen free (SPF) conditions. Human fetal liver was obtained from Advanced Bioscience Resources, CA. The tissue was minced and treated with 2 mg/ml collagenase D (Roche Diagnostics, IN) in HBSS with CaCl 2 /MgCl 2 for 30 minutes at room temperature followed by filtering through 70 m nylon cell strainers (BD Biosciences, CA). CD34 + human hematopoietic stem and progenitor cells (HPCs) were isolated using the direct CD34 MicroBead Kit (Miltenyi Biotec, CA). 2-5 days old NSG mice were irradiated with 100 cGy and injected intrahepatically with 1-2 x 10 5 CD34 + HPCs 6 h post irradiation. The mice were bled 10-12 weeks post engraftment and peripheral lymphocytes were analyzed by FACS as described previously (26) (27) to check for the reconstitution of the human immune system. Animal protocols were approved by the Institutional Animal Care and Use Committee of the Rockefeller University and the Cantonal Veterinary Office Zürich.
Isolation of blood mononuclear cells

Peripheral blood (PB) from healthy adult volunteers was obtained as part of Institutional
Review Board-approved protocols from the New York, Liguria and Zürich Blood Centers.
Human cord blood (CB) samples were kindly provided by the Liguria Cord Blood Bank (San Martino Hospital, Genoa, Italy) after delivery of the infant and after prior need for clinical samples had been satisfied. Samples were collected from full term mothers upon their informed consent for research purpose, according to the declaration of Helsinki.
Cord blood was processed within 16 h after birth to secure viability of cells. Cord Blood and peripheral blood were diluted 1:4 or 1:2 with PBS, respectively, and mononuclear cells (CBMCs/PBMCs) were isolated by density-gradient centrifugation on Ficoll/Hypaque. Cells were either directly analyzed or cryopreserved for further analyses.
Purified NK cells were obtained by negative selection using NK Cell Isolation Kits (Miltenyi Biotec).
Isolation of cells from tissues of hu-NSG mice
For isolation of cells from spleen and lung, organs were minced and treated with 2 mg/ml collagenase D in HBSS with CaCl 2 /MgCl 2 for 30 minutes at RT followed by filtering through 70 m nylon cell strainers. Livers of mice were perfused with PBS to remove blood for the isolation of liver-resident cells and subsequently single cell suspensions were generated as described for spleen and lung. Single cell suspensions from lymph nodes were generated by meshing the organs through 70 m nylon cell strainers.
Contaminating erythrocytes in cell suspensions were lysed using ACK lysis buffer or removed by density-gradient centrifugation on Ficoll/Hypaque, and remaining cells were washed, and subjected to subsequent analysis and functional assays. Purified NK cells were obtained by negative selection using NK Cell Isolation Kits, supplemented with anti-mouse CD45 antibodies (Miltenyi Biotec).
Generation of polyclonal NK cell lines
In order to generate polyclonal NK cells from mice with reconstituted human immune system components, murine cells were depleted from splenocytes using anti-mouse CD45 microbeads und human cells were subsequently cultured in medium with 100 IU/ml of IL-2. Cells were split upon becoming confluent and medium was replaced. After two weeks cell cultures contained >95% human NK cells (hCD45 + NKp46 + ) as analyzed by flow cytometry.
Degranulation assay
To characterize the functional capacities of NK cells within bulk cell populations, we stimulated bulk cells (splenocytes, cord blood mononuclear cells, peripheral blood mononuclear cells, respectively) with target cells at an effector to target ratio of 1:1 for 6 h in the presence of anti-CD107a antibody. To detect spontaneous degranulation and cytokine production, a control without target cells was included. After 1 h, monensin (Sigma-Aldrich, 1µg/ml) was added to all samples. At the end of the incubation, cells were stained on ice with antibodies against human CD45, CD3, and NKp46, washed, fixed, permeabilized, and finally labeled with an anti-IFN- antibody. Cells were subsequently analyzed by flow cytometry.
Cytotoxicity assay
To evaluate the cytotoxic activity of NK cells against the K562 target cell line, cytotoxicity assays were performed, as previously described (16) . Briefly, target cells were labeled with PKH26 (Sigma-Aldrich), and then incubated with NK cell lines at the indicated effector/target ratios. After 4 h, cells were harvested; TO-PRO-3-iodide, a membraneimpermeable DNA stain, was added to each culture (0.5 µM final concentration); and cells were finally analyzed by flow cytometry. Background and maximum TO-PRO-3- 
Adoptive transfer of purified NK cell populations
CD3 -NKp46 + CD56cells from pooled spleens of hu-NSG mice were sorted to high purity (>98%) on a FACS Aria (BD Biosciences) and labelled with 5 µM CFSE. 1-2 x 10 5 of sorted cells were adoptively transferred into recipient hu-NSG mice (reconstituted with same CD34 + HPCs as donor hu-NSG mice), which were sacrificed 48 h later. Recovered NKp46 + CFSE + cells from spleens were then analyzed for CD56 expression by flow cytometry.
Monoclonal Antibodies and Flow Cytometry
Analysis of cell surface markers was performed using the following mAbs: V450- 
Statistical Analysis
Statistical analyses were performed using the Graph-Pad Prism v. 4.00 for Windows (GraphPad Software, San Diego, CA). Statistical significance was evaluated by twotailed Student t-test.
Results
NOD-scid IL2R null mice reconstitute human NK cells from CD34 + hematopoietic progenitor cells
In order to reconstitute human immune system components in NSG mice, we injected mice neonatally with 10 5 human CD34 + hematopoietic stem and progenitor cells intrahepatically (27) (28) . After three month we monitored human B cell, T cell, monocyte, dendritic cell and NK cell reconstitution. As previously reported (27) around 60-80% of mononuclear splenocytes were of human origin at this timepoint. Of these 50-60% were B cells, 25-30% were T cells (CD4:CD8 ratio 3:2), 1-2% were plasmacytoid dendritic cells (DCs), 1-2% were conventional DCs, 3-5% were monocytes and 1-3% were NK cells. We decided to characterize the human NK cell distribution further. Compared to spleen, we found higher percentages of CD3 -NKp46 + NK cells in lung, blood and liver, while below 1% of mononuclear cells of the bone marrow were NK cells ( Figure 1A and B). In lung, the organ with the highest NK cell fraction, up to 7% NK cells were detected. However, when taking total cell numbers for these organs into account, spleen and liver constituted the largest NK cell reservoirs after reconstitution ( Figure 1C ). These data suggest that human NK cells reconstitute in NSG mice with human immune system components (hu-NSG), and they are present in all strongly blood perfused organs.
Hu-NSG mice and cord blood contain a NKp46 + CD56 -NK cell subset
In order to characterize the NK cell subsets that were developing in hu-NSG mice we performed phenotyping of the splenic NK cell compartment. We found KIR, CD94, NKG2D, NKp46, NKG2A and CD16 expression on splenic CD3 -CD56 + NK cells ( Figure   2A ). In comparison to human spleen, whose NK cell compartment is in the majority composed of CD56 dim CD16 + NK cells (75%) (16) , the minority of hu-NSG derived splenic NK cells belonged to this terminally differentiated subset (25-40%), suggesting a more immature NK cell compartment in hu-NSG mice compared to human adult spleen.
Interestingly, in addition to CD56 bright CD16and CD56 dim CD16 + NK cells, hu-NSG spleen contained a large subpopulation of NKp46 + CD56 -NK cells ( Figure 2B ). Part of these carried in addition to NKp46 other NK cell markers like NKG2A and CD16. Some of the NKp46 + CD56 -CD16 + NK cells expressed KIRs (20-30%), while minimal or no KIR expression was detected on CD16 -NK cells ( Figure 2C ). Vice versa, a subset of CD3 -NKp46 + CD56 -CD16cells stained positive for CD127 and CD117, and could therefore constitute stage 3 NK cell precursors (29) . Since CD56 is up-regulated during human NK cell activation (30) , we considered the possibility that the NKp46 + CD56 -NK cells might be a resting NK cell population prior to a history of pathogen exposure. In order to provide more evidence for this hypothesis, we investigated human cord blood in order to determine if this NK cell subpopulation also existed prior to human pathogen exposure.
Indeed, we found within NKp46 + cord blood NK cells both CD56 and CD16 negative cells ( Figure 2D ). The frequency of these NKp46 + CD56 -NK cells was in contrast very low in adult blood (around 3%). NKp46 + CD56 -NK cells constituted around 15% of cord blood NK cells amounting in some cord blood samples to up to 30% of the human NK cell compartment ( Figure 2E ). In order to determine if indeed these CD3 -NKp46 + CD56cells can differentiate into CD3 -NKp46 + CD56 + NK cells, we adoptively transferred purified and CFSE labeled CD3 -NKp46 + CD56cells into hu-NSG mice reconstituted with autologous CD34 + HPCs by intravenous injection. After 48 h, NKp46 + CFSE + cells were recovered from recipient spleens and analyzed for their CD56 expression ( Figure 2F ). All recovered cells had up-regulated CD56. Similarly, CD3 -NKp46 + CD56cells from hu-NSG mice up-regulated CD56 after activation in vitro (Supplemental Figure 1) . These data suggest that spleens of recently reconstituted hu-NSG mice and human cord blood contains a NKp46 + CD56 -NK cell population that constitutes around 50% of NK cells in hu-NSG mice and up to 30% of NK cells in human cord blood, and can differentiate into NKp46 + CD56 + NK cells in vitro and in vivo.
NK cells from hu-NSG mice have a decreased ability for cytotoxicity and IFN- production compared to NK cells from human adults
The functional capacity of NK cells from hu-NSG mice was evaluated by ex vivo stimulation with two NK cell susceptible human target cell lines, the erythroleukemia cell line K562 and the T cell lymphoma line CEM, as well as by monokine stimulation (IL-12+IL15). While K562 is recognized by a combination of NCR, NKG2D and DNAM-1 mediated mechanisms, triggering all NK cell subsets, CEM mediated stimulation of NK cells is primarily mediated by NKG2D and affects mainly CD56 bright CD16 -NK cells (31) .
As a surrogate marker for cytotoxicity, degranulation of NK cells in response to these stimuli was assessed by CD107a staining and intracellular IFN- staining was monitored as a representative measure for cytokine production ( Figure 3A ). NK cells from hu-NSG mice degranulated slightly less than human adult peripheral blood NK cells in response to K562 cells. Strikingly, a nearly tenfold difference, was, however, seen in IFN- production in response to K562 cells ( Figure 3B ). Interestingly, NKG2D mediated recognition of CEM was similar between NK cells from hu-NSG mice and human adult blood. When we analyzed K562 recognition by the different NK cell subsets of hu-NSG mice, the functional defect was primarily confined to CD56 dim and NKp46 + CD56 -NK cells ( Figure 3C) . Similarly, NK cells from cord blood degranulated less efficiently in response to K562 than human adult blood NK cells, and this deficiency was primarily confined to CD56 dim and NKp46 + CD56 -NK cells ( Figure 3D) . The same NK cell subsets also produced less IFN-, when restimulated with K562 cells (data not shown). These data suggest that the resting NK cell compartment of hu-NSG mice degranulate and produce cytokines less efficiently upon cognate target recognition than human adult NK cells, and part of this deficiency is caused by the CD56 dim and NKp46 + CD56 -NK cell populations.
IL-15 mediated pre-activation can overcome the functional deficiency of NK cells from hu-NSG mice
Since NK cell pre-activation by mature DCs has recently been identified as crucial for full functional capacity of these innate lymphocytes (8, (32) (33) (34) (35) ), we exposed hu-NSG splenocytes to the monokines IL-12 and IL-15 as well as the DC maturing TLR3/mda5 ligand polyinosinic:polycytidylic acid (poly I:C or p(I:C)). Degranulation in response to K562 and CEM was markedly enhanced by IL-15 or poly I:C pre-activation ( Figure 4A ).
In addition, IFN- production by hu-NSG NK cells after stimulation with K562 and CEM was boosted five-to tenfold after pre-activation with IL-15 or poly I:C in vitro ( Figure 4B ).
Poly I:C was only able to enhance degranulation and IFN- production by NK cells, when bystander cells, presumably mainly DCs, were present, while purified NK cells from hu-NSG mice or cord blood only increased their degranulation and cytokine production in response to K562 after pre-activation with IL-15, but not poly I:C (Figures 4C to F) . From these data we conclude that NK cells from hu-NSG mice and cord blood have a similar functional capacity as human adult blood NK cells, but require pre-activation to respond efficiently to cognate target cells, while adult NK cells have a higher constitutive reactivity, possibly due to pre-activation by environmental stimuli.
Pre-activation increases perforin and granzyme B content in NK cells of hu-NSG mice
In addition to the functional parameters of degranulation and IFN- production, we also tested if the cytotoxic armament of hu-NSG NK cells increased upon pre-activation in vitro. For this purpose we stained intracellularly for perforin and granzyme B in CD3 -NKp46 + NK cells of hu-NSG splenocyte cultures that had been exposed to poly I:C or the monokines IL-12 and IL-15. Both IL-15 and poly I:C addition were able to increase the perforin and granzyme B content of hu-NSG mice around fivefold (Supplemental Figure 2A and B) . Analogous to the in vitro activation data, the frequency of perforin expressing cells was only increased after IL-15 stimulation of purified splenic NK cells, while poly I:C was not able to induce cytotoxic granules directly (Supplemental Figure   2C ). Therefore, pre-activation of NK cells via bystander cell maturation with poly I:C or direct stimulation by IL-15 increases both degranulation capacity and cytotoxic effector molecule expression of NK cells from hu-NSG mice.
Pre-activation boosts degranulation and cytokine production in terminally differentiated NK cells of hu-NSG mice
Since we had noted that primarily CD56 dim and NKp46 + CD56 -NK cells of hu-NSG mice and cord blood were functionally deficient in comparison to adult peripheral blood NK cells, we wondered if IL-15 mediated pre-activation would affect these NK cell compartments. We confirmed that these NK cell compartments of hu-NSG mice contained CD16 + KIR + terminally differentiated human NK cells ( Figure 5A and B) , and that CD16 expression was not altered on purified NK cells from these subsets during one day of IL-15 activation, while CD56 was up-regulated during this activation period (Supplemental Figure 1 and data not shown) . This allowed us to analyze degranulation and cytokine production of CD16 + terminally differentiated hu-NSG NK cells in response to K562 stimulation after IL-15 pre-activation. Indeed, degranulation and IFN- production by these NK cells were significantly, around 5 fold, elevated after preactivation in response to K562 stimulation ( Figure 5C and D) . In addition, CD16 -NK cells also up-regulated IFN- production and degranulation in response to K562 cells after exposure to IL-15. Thus, the functional deficiency of terminally differentiated NK cells in hu-NSG mice can be overcome by pre-activation with IL-15.
NK cells from hu-NSG mice display cytotoxic function against K562 cells
So far we tested degranulation and cytotoxic molecule expression as surrogate markers for NK cell cytotoxicity of hu-NSG mice. In order to demonstrate cytotoxicity against K562 cells by human reconstituted NK cells from hu-NSG mice directly, we established NK cell lines from hu-NSG mice ( Figure 6A ). These lines contained to more than 95% NKp46 + NK cells with partial KIR expression. They were comparable or slightly superior to a NK cell lines established from adult human blood with respect to perforin and granzyme B expression. We used the To-Pro-3 incorporation assay as a measurement of direct cytotoxicity (9, 16, 36) . The NK cell lines from hu-NSG mice killed K562 with high efficiency of more than 70% lysed cells already at a 10:1 NK:K562 ratio ( Figure 6B ). This suggests that NK cells from hu-NSG mice are functionally competent, but require cytokine pre-activation to reach their full functional potential.
Poly I:C administration enhances human NK cell functions in vivo
The above described experiments documented the composition and functions of NK cells from hu-NSG mice ex vivo and after activation in vitro. However, in order to assess the capacity of these innate lymphocyte to become functional effectors in vivo, we 
Discussion
Our study assessed human NK cell reconstitution from CD34 + hematopoietic stem and progenitor cells in NOD-scid IL2R null mice (NSG). We found reconstitution of NK cell subsets that are similar to human cord blood, differing by the additional presence of NKp46 + CD56 -NK cells from the subpopulations found in human adult blood. The human NK cell reconstitution in hu-NSG mice is with respect to NK cell subset distribution similar to human NK cell development in BALB/c Rag2 -/- c -/mice (22) , in which also NKp46 + CD56 -, CD56 bright CD16 -KIRand CD56 dim CD16 + KIR + NK cell populations could be observed. Interestingly, however, in all investigated organs except for bone marrow, the frequency of developing NK cells was five-to tenfold lower in reconstituted BALB/c Rag2 -/- c -/versus hu-NSG mice (22, 37) . This suggests that while NK cell development in the bone marrow progresses to similar levels in these two immunodeficient mouse strains, human NK cells survive and, therefore, accumulate to higher levels in NSG mice. The lower myeloid xenoreactivity mediated by cross-reactivity of NOD SIRP- towards human CD47 (38) could be in part responsible for this better NK cell reconstitution. However, human NK cells in BALB/c Rag2 -/- c -/mice were able to delay K562 tumor growth in vivo (39) and can be expanded in BALB/c Rag2 -/- c -/mice by IL-15 or IL-15/IL-15R hybrid molecule administration, reaching then levels of steadystate NK cell reconstitution in NSG mice (22) . This expansion occurs at the expense of the CD16 negative NK cell subsets and converts nearly all NK cells to CD16 + partially KIR + NK cells. A similar NK cell expansion could also be induced in reconstituted NSG mice by hydrodynamic delivery of IL-15 encoding expression plasmids, but the effect on NK cell subset differentiation was not investigated in detail in this study (40) . Therefore, we propose that the more efficient NK cell subset reconstitution in hu-NSG mice recommends this model for studying immune responses mediated by these human innate lymphocytes in vivo.
In addition to this essential role of IL-15 for NK cell development and accumulation, which was also previously reported for mouse NK cells (41) (42) , IL-15 has also been shown to be required for pre-activation of mouse NK cells to reach their full functional potential (35) . During viral and bacterial infections this NK cell pre-activation is performed by DCs, possibly via IL-15 trans-presentation (35) . Similarly in humans, DCs can activate NK cells to produce cytokines, proliferate and acquire elevated cytotoxicity (8, (32) (33) (43) (44) (45) . Thus reconstituted human NK cells of hu-NSG mice resemble resting NK cells, which like mouse NK cells from animals housed under pathogen free conditions, require pre-activation to become fully functional. In contrast, human adult NK cells display a higher constitutive reactivity, because they are probably partially preactivated through continuous pathogen encounter. Especially the CD56 dim CD16 + NK cells required this pre-activation step, while CD56 bright CD16 -NK cells demonstrated already significant reactivity against K562 cells ex vivo, quite similar to CD56 bright CD16 -NK cells from human adult blood. These findings are consistent with a previous report, which also suggested that deficiency in NK cell reactivity of human cord blood was primarily confined to CD56 dim CD16 + NK cells (46) . This suggests that primarily terminally differentiated human NK cells require pre-activation. We also identified IL-15 as a potent mediator of human NK cell pre-activation in hu-NSG mice, and poly I:C mediated maturation for NK cell pre-activation probably primarily affected also human DCs to fulfill this function. Indeed, we have previously shown that poly I:C mediated DC maturation renders these cells more efficient in NK cell stimulation than other maturation stimuli Altogether, our data point towards functional competence of resting human NK cells that develop from CD34 + hematopoietic stem and progenitor cells in hu-NSG mice.
We propose that this model could allow the study of NK cell responses during infection with lymphotrophic human pathogens like the Epstein Barr virus (27) . These studies could reveal the contribution of NK cells to initial pathogen restriction and priming of protective immune control. Such information could then be harnessed to develop vaccination approaches against human pathogens.
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